 Patrick Hu
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 23 | 2021 | 337 | 5.490 |
Why?
| | Caenorhabditis elegans Proteins | 14 | 2019 | 210 | 3.550 |
Why?
| | Longevity | 9 | 2015 | 173 | 1.980 |
Why?
| | Coronary Vasospasm | 6 | 2024 | 8 | 1.470 |
Why?
| | Forkhead Transcription Factors | 7 | 2015 | 202 | 1.250 |
Why?
| | Insulin | 7 | 2021 | 2507 | 1.210 |
Why?
| | Gene Expression Regulation, Developmental | 9 | 2020 | 905 | 1.050 |
Why?
| | Mutagenesis | 3 | 2016 | 192 | 0.980 |
Why?
| | Transcription Factors | 6 | 2013 | 1741 | 0.830 |
Why?
| | Mutation | 16 | 2017 | 4089 | 0.790 |
Why?
| | Research Personnel | 6 | 2026 | 186 | 0.740 |
Why?
| | Starvation | 1 | 2020 | 23 | 0.660 |
Why?
| | Life Cycle Stages | 1 | 2020 | 37 | 0.650 |
Why?
| | Physicians | 7 | 2026 | 939 | 0.640 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 209 | 0.630 |
Why?
| | Signal Transduction | 12 | 2021 | 5226 | 0.630 |
Why?
| | Receptors, Peptide | 1 | 2019 | 18 | 0.620 |
Why?
| | Ethylnitrosourea | 2 | 2016 | 13 | 0.610 |
Why?
| | Career Choice | 5 | 2026 | 237 | 0.600 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 219 | 0.560 |
Why?
| | Aging | 3 | 2020 | 1966 | 0.550 |
Why?
| | Arrhythmias, Cardiac | 2 | 2023 | 361 | 0.550 |
Why?
| | Biomedical Research | 6 | 2026 | 710 | 0.520 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 496 | 0.510 |
Why?
| | RNA Splice Sites | 1 | 2016 | 50 | 0.480 |
Why?
| | Genome, Helminth | 1 | 2015 | 3 | 0.470 |
Why?
| | Sensory Receptor Cells | 1 | 2017 | 101 | 0.470 |
Why?
| | Myocardial Infarction | 2 | 2020 | 1209 | 0.450 |
Why?
| | Introns | 1 | 2016 | 254 | 0.450 |
Why?
| | Cholestenes | 3 | 2014 | 4 | 0.440 |
Why?
| | Environment | 1 | 2017 | 305 | 0.440 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.440 |
Why?
| | Gene Rearrangement | 1 | 2015 | 155 | 0.430 |
Why?
| | Animals | 23 | 2021 | 38058 | 0.430 |
Why?
| | Lysine | 1 | 2017 | 302 | 0.430 |
Why?
| | Neuronal Plasticity | 1 | 2017 | 309 | 0.410 |
Why?
| | Dosage Compensation, Genetic | 1 | 2013 | 11 | 0.400 |
Why?
| | Steroids | 2 | 2014 | 160 | 0.390 |
Why?
| | Microbiota | 1 | 2021 | 781 | 0.390 |
Why?
| | Receptor, Insulin | 5 | 2013 | 94 | 0.380 |
Why?
| | Hormones | 1 | 2013 | 134 | 0.370 |
Why?
| | Embryonic Development | 1 | 2013 | 125 | 0.370 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2013 | 319 | 0.370 |
Why?
| | Granulosa Cell Tumor | 1 | 2011 | 6 | 0.360 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2011 | 20 | 0.350 |
Why?
| | Genome | 1 | 2014 | 306 | 0.350 |
Why?
| | Internal Medicine | 2 | 2025 | 280 | 0.350 |
Why?
| | Transcription, Genetic | 2 | 2015 | 1496 | 0.340 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2011 | 40 | 0.340 |
Why?
| | Histones | 1 | 2017 | 669 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2010 | 436 | 0.340 |
Why?
| | Coronary Vessels | 3 | 2023 | 251 | 0.330 |
Why?
| | Spasm | 2 | 2022 | 21 | 0.330 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2014 | 549 | 0.330 |
Why?
| | Genomics | 2 | 2015 | 834 | 0.320 |
Why?
| | Heart Failure | 2 | 2023 | 2323 | 0.320 |
Why?
| | Models, Biological | 7 | 2017 | 1821 | 0.310 |
Why?
| | beta Catenin | 1 | 2011 | 252 | 0.300 |
Why?
| | Genetic Variation | 1 | 2014 | 983 | 0.290 |
Why?
| | MAP Kinase Signaling System | 2 | 2022 | 310 | 0.270 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 630 | 0.260 |
Why?
| | Genes, Helminth | 4 | 2013 | 30 | 0.260 |
Why?
| | Recombinant Fusion Proteins | 3 | 2019 | 675 | 0.240 |
Why?
| | Carrier Proteins | 1 | 2010 | 737 | 0.240 |
Why?
| | Genetic Techniques | 1 | 2006 | 67 | 0.240 |
Why?
| | Education, Medical | 2 | 2020 | 274 | 0.240 |
Why?
| | Ovarian Neoplasms | 1 | 2011 | 586 | 0.230 |
Why?
| | Genes, X-Linked | 2 | 2017 | 21 | 0.230 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2006 | 167 | 0.220 |
Why?
| | Chromosome Mapping | 3 | 2016 | 510 | 0.220 |
Why?
| | Base Sequence | 3 | 2016 | 2190 | 0.210 |
Why?
| | Internship and Residency | 3 | 2024 | 1257 | 0.200 |
Why?
| | Larva | 3 | 2017 | 242 | 0.200 |
Why?
| | Syndrome | 2 | 2023 | 380 | 0.190 |
Why?
| | Apoprotein(a) | 1 | 2022 | 8 | 0.180 |
Why?
| | Coronary Angiography | 2 | 2023 | 323 | 0.180 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2016 | 2145 | 0.170 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 557 | 0.170 |
Why?
| | Lipoprotein(a) | 1 | 2022 | 68 | 0.170 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2020 | 23 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2022 | 193 | 0.160 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 439 | 0.160 |
Why?
| | Animals, Genetically Modified | 3 | 2013 | 250 | 0.160 |
Why?
| | Coronary Artery Disease | 2 | 2019 | 741 | 0.160 |
Why?
| | Interleukin-6 | 2 | 2022 | 780 | 0.160 |
Why?
| | Lysosomes | 1 | 2020 | 128 | 0.160 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 405 | 0.150 |
Why?
| | Protein Precursors | 1 | 2019 | 137 | 0.150 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 120 | 0.140 |
Why?
| | Phenotype | 3 | 2016 | 3162 | 0.140 |
Why?
| | Cytochrome P-450 Enzyme System | 2 | 2010 | 162 | 0.140 |
Why?
| | Education | 1 | 2018 | 104 | 0.140 |
Why?
| | Taiwan | 3 | 2024 | 46 | 0.130 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2018 | 93 | 0.130 |
Why?
| | Metabolic Networks and Pathways | 2 | 2020 | 187 | 0.130 |
Why?
| | Alleles | 2 | 2011 | 879 | 0.120 |
Why?
| | Phylogeny | 1 | 2021 | 1016 | 0.120 |
Why?
| | Electrocardiography | 1 | 2020 | 662 | 0.120 |
Why?
| | Nucleotide Motifs | 1 | 2016 | 36 | 0.120 |
Why?
| | Chromosome Breakpoints | 1 | 2015 | 9 | 0.120 |
Why?
| | RNA Splicing Factors | 1 | 2016 | 64 | 0.120 |
Why?
| | X Chromosome | 1 | 2015 | 67 | 0.120 |
Why?
| | Sequence Deletion | 1 | 2016 | 193 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2019 | 387 | 0.120 |
Why?
| | Receptors, Somatomedin | 1 | 2015 | 5 | 0.120 |
Why?
| | Anxiety Disorders | 1 | 2019 | 373 | 0.120 |
Why?
| | Stents | 1 | 2020 | 556 | 0.110 |
Why?
| | Propensity Score | 3 | 2024 | 367 | 0.110 |
Why?
| | Gene Dosage | 1 | 2015 | 148 | 0.110 |
Why?
| | Monocytes | 1 | 2018 | 538 | 0.110 |
Why?
| | Humans | 21 | 2026 | 144759 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2011 | 2930 | 0.110 |
Why?
| | Ligands | 2 | 2014 | 673 | 0.110 |
Why?
| | Societies, Medical | 1 | 2018 | 887 | 0.100 |
Why?
| | Tyrosine Transaminase | 1 | 2013 | 4 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2015 | 402 | 0.100 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 550 | 0.100 |
Why?
| | Tyrosine | 1 | 2013 | 222 | 0.100 |
Why?
| | Germ Cells | 1 | 2013 | 66 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 824 | 0.090 |
Why?
| | RNA Interference | 2 | 2013 | 476 | 0.090 |
Why?
| | Male | 10 | 2024 | 72315 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2583 | 0.090 |
Why?
| | Genes, Dominant | 1 | 2011 | 101 | 0.090 |
Why?
| | Loss of Heterozygosity | 1 | 2011 | 52 | 0.090 |
Why?
| | Codon | 1 | 2011 | 94 | 0.090 |
Why?
| | Female | 10 | 2024 | 78271 | 0.090 |
Why?
| | Transgenes | 2 | 2010 | 189 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2017 | 790 | 0.080 |
Why?
| | Oxidative Stress | 1 | 2018 | 1339 | 0.080 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2024 | 140 | 0.080 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 2010 | 9 | 0.080 |
Why?
| | Oxygenases | 1 | 2010 | 13 | 0.080 |
Why?
| | Awards and Prizes | 2 | 2024 | 70 | 0.080 |
Why?
| | Gene Silencing | 1 | 2011 | 205 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2010 | 121 | 0.080 |
Why?
| | Transcriptome | 1 | 2017 | 1045 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2273 | 0.080 |
Why?
| | Disease | 1 | 2010 | 98 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1782 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2155 | 0.080 |
Why?
| | Wnt Signaling Pathway | 1 | 2011 | 210 | 0.080 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2009 | 109 | 0.070 |
Why?
| | Phosphorylation | 1 | 2013 | 1732 | 0.070 |
Why?
| | Middle Aged | 7 | 2024 | 35875 | 0.070 |
Why?
| | Biological Assay | 1 | 2009 | 128 | 0.070 |
Why?
| | Drug Design | 1 | 2009 | 173 | 0.070 |
Why?
| | DNA, Helminth | 1 | 2008 | 26 | 0.070 |
Why?
| | Metabolomics | 1 | 2014 | 727 | 0.070 |
Why?
| | Models, Chemical | 1 | 2009 | 269 | 0.070 |
Why?
| | Osteoporosis | 1 | 2010 | 236 | 0.070 |
Why?
| | Pheromones | 1 | 2007 | 22 | 0.070 |
Why?
| | Chemoreceptor Cells | 1 | 2007 | 51 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2008 | 540 | 0.060 |
Why?
| | DNA Primers | 1 | 2008 | 512 | 0.060 |
Why?
| | Genotype | 1 | 2011 | 1833 | 0.060 |
Why?
| | Aged | 6 | 2024 | 25913 | 0.060 |
Why?
| | Databases, Factual | 2 | 2024 | 1486 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2006 | 396 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1455 | 0.060 |
Why?
| | Cohort Studies | 3 | 2022 | 5960 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1054 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2008 | 618 | 0.050 |
Why?
| | Mentors | 1 | 2026 | 219 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 862 | 0.050 |
Why?
| | Education, Graduate | 1 | 2023 | 36 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 612 | 0.050 |
Why?
| | Death, Sudden | 1 | 2023 | 24 | 0.050 |
Why?
| | Transfection | 2 | 2022 | 940 | 0.050 |
Why?
| | Peptides | 1 | 2009 | 995 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2024 | 17066 | 0.050 |
Why?
| | Angina Pectoris | 1 | 2023 | 75 | 0.050 |
Why?
| | Cell Membrane | 1 | 2006 | 706 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3604 | 0.050 |
Why?
| | DNA | 1 | 2009 | 1463 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1257 | 0.040 |
Why?
| | Disease Progression | 1 | 2009 | 2847 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 479 | 0.040 |
Why?
| | United States | 3 | 2025 | 15966 | 0.040 |
Why?
| | Glucosides | 1 | 2020 | 55 | 0.040 |
Why?
| | Nobel Prize | 1 | 2020 | 6 | 0.040 |
Why?
| | Organelles | 1 | 2020 | 57 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2020 | 366 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2024 | 768 | 0.040 |
Why?
| | Drug-Eluting Stents | 1 | 2020 | 88 | 0.040 |
Why?
| | Proteome | 1 | 2004 | 518 | 0.040 |
Why?
| | Charities | 1 | 2018 | 13 | 0.040 |
Why?
| | Foundations | 1 | 2018 | 27 | 0.040 |
Why?
| | Training Support | 1 | 2018 | 36 | 0.040 |
Why?
| | Inflammation | 2 | 2022 | 2878 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 10779 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 357 | 0.030 |
Why?
| | Prospective Studies | 2 | 2022 | 7990 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6048 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 11679 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 291 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2020 | 8265 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2608 | 0.030 |
Why?
| | Nicotinic Agonists | 1 | 2018 | 136 | 0.030 |
Why?
| | Risk | 1 | 2019 | 911 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1325 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2018 | 416 | 0.030 |
Why?
| | Nicotine | 1 | 2018 | 331 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2112 | 0.030 |
Why?
| | Angina Pectoris, Variant | 1 | 2014 | 3 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2879 | 0.030 |
Why?
| | Adult | 3 | 2024 | 40449 | 0.030 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2020 | 543 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1658 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2014 | 131 | 0.030 |
Why?
| | Students, Medical | 1 | 2018 | 375 | 0.030 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 165 | 0.020 |
Why?
| | Age Factors | 1 | 2021 | 3333 | 0.020 |
Why?
| | Organ Specificity | 1 | 2014 | 312 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7173 | 0.020 |
Why?
| | Mice | 1 | 2010 | 18339 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5408 | 0.020 |
Why?
| | Smoking | 1 | 2018 | 1472 | 0.020 |
Why?
| | Cosmids | 1 | 2004 | 8 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 59 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14105 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2004 | 132 | 0.010 |
Why?
| | Child | 1 | 2022 | 22633 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 635 | 0.010 |
Why?
| | Cell Line | 1 | 2004 | 2882 | 0.010 |
Why?
| | Kidney | 1 | 2004 | 1495 | 0.010 |
Why?
|
|
Hu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|